The article discusses how coating of stents with anti-inflammatory and anti-proliferative drugs such as sirolimus and paclitaxel can help lowering rates of restenosis and prohibiting endothelial dysfunction. Topics discussed include vascular remodeling and inflammatory response during restenosis, angiogenesis and inflammation in formation of atherosclerotic plaque, and use of endothelial cell proliferation and activation to prevent restenosis.